Nexgel (NXGLW) Depreciation & Amortization (CF) (2018 - 2025)
Nexgel (NXGLW) reported Depreciation & Amortization (CF) of $112000.0 for Q4 2025, up 3.7% on a YoY basis from $108000.0 in Q4 2024, and down 0.88% quarter-over-quarter from $113000.0 in Q3 2025.
Nexgel (NXGLW) Depreciation & Amortization (CF) (2018 - 2025) Analysis & Trends
Nexgel has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $112000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 3.7% year-over-year to $112000.0; the trailing twelve-month figure through Dec 2025 stood at $450000.0 (up 3.21% YoY), and the FY2025 full-year result was $450000.0, up 3.21% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $112000.0, down from $113000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $184000.0 in Q3 2024, with the low at -$93000.0 in Q4 2021.
- Historically, Depreciation & Amortization (CF) has averaged $66850.0 across 5 years, with a median of $49500.0 in 2023.
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) tumbled 365.0% — and 2024, when it jumped 425.71%.
- Nexgel's Depreciation & Amortization (CF) stood at -$93000.0 in 2021, then jumped by 130.11% to $28000.0 in 2022, then soared by 339.29% to $123000.0 in 2023, then dropped by 12.2% to $108000.0 in 2024, then advanced by 3.7% to $112000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $112000.0 (Q4 2025), $113000.0 (Q3 2025), and $111000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Nexgel | - | - | 819,000.00 | 112,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112,000.00 |
| Dec 31, 2025 | 112,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 123,000.00 |
| Dec 31, 2023 | 123,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Sep 30, 2023 | 35,000.00 |